High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

Christopher J. Gamper, Clifford M. Takemoto, Allen R. Chen, Heather J. Symons, David M. Loeb, James F. Casella, Amy E. Dezern, Karen E. King, Andrea M. McGonigle, Richard J. Jones, Robert A. Brodsky

Research output: Contribution to journalArticle

10 Scopus citations
Original languageEnglish (US)
Pages (from-to)627-635
Number of pages9
JournalJournal of Pediatric Hematology/Oncology
Volume38
Issue number8
DOIs
StatePublished - Nov 1 2016

    Fingerprint

Keywords

  • clinical trials
  • pediatric hematology/oncology
  • severe aplastic anemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Gamper, C. J., Takemoto, C. M., Chen, A. R., Symons, H. J., Loeb, D. M., Casella, J. F., Dezern, A. E., King, K. E., McGonigle, A. M., Jones, R. J., & Brodsky, R. A. (2016). High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia. Journal of Pediatric Hematology/Oncology, 38(8), 627-635. https://doi.org/10.1097/MPH.0000000000000647